Science
The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract the coronavirus, a successful antibody treatment could have a marked effect on lowering the pandemic’s death toll. Riley Griffin talks about the new drug, and the promise of antibody treatments.
See omnystudio.com/listener for privacy information.
More Episodes
Can Drugstores Save Us?
2021-01-22
2021-01-22
The Global Vaccine Gap
2021-01-20
2021-01-20
Where to Be in a Pandemic (Rebroadcast)
2021-01-18
2021-01-18
Can We Fix the Chaotic Vaccine Rollout?
2021-01-15
2021-01-15
Why Healthcare Workers Refuse the Vaccine
2021-01-13
2021-01-13
What Allergic Vaccine Reactions Mean For You
2021-01-11
2021-01-11
The U.K. Health System Threatens to Buckle
2021-01-08
2021-01-08
Vaccines via Eventbrite
2021-01-06
2021-01-06
How It All Started (Rebroadcast)
2021-01-01
2021-01-01
What We Know About Covid's Origins
2020-12-30
2020-12-30
A New Technology Hiding in Covid Vaccines
2020-12-23
2020-12-23
Lessons From Past Vaccines
2020-12-21
2020-12-21
Voices From the U.S. Vaccine Program
2020-12-16
2020-12-16
Louisiana's Vaccine Test Run
2020-12-14
2020-12-14
Who Should Get the First Doses?
2020-12-09
2020-12-09
A Turning Point Week Ahead
2020-12-07
2020-12-07
The Struggle to Distribute the Vaccine
2020-12-04
2020-12-04
Get this podcast on your
phone, FREE
